Testing Mitochondrial-Targeted Drugs in iPSC-RPE from Patients with Age-Related Macular Degeneration.

Ebeling, Mara C; Geng, Zhaohui; Stahl, Madilyn R; Kapphahn, Rebecca J; Roehrich, Heidi; Montezuma, Sandra R; Ferrington, Deborah A; Dutton, James R

Ebeling, Mara C; Geng, Zhaohui; Stahl, Madilyn R; Kapphahn, Rebecca J; Roehrich, Heidi; Montezuma, Sandra R; Ferrington, Deborah A; Dutton, James R.

Afiliação

Ebeling MC; Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN 55455, USA.
Geng Z; Stem Cell Institute, University of Minnesota, Minneapolis, MN 55455, USA.
Stahl MR; Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, MN 55455, USA.
Kapphahn RJ; Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN 55455, USA.
Roehrich H; Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN 55455, USA.
Montezuma SR; Histology Core for Vision Research, University of Minnesota, Minneapolis, MN 55455, USA.
Ferrington DA; Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN 55455, USA.
Dutton JR; Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN 55455, USA.

Pharmaceuticals (Basel) ; 15(1)2022 Jan 04.

Article em En | MEDLINE | ID: mdl-35056119

Palavras-chave

age-related macular degeneration; human-induced pluripotent stem cells; personalized drug testing; retinal pigment epithelium

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google